Table 2. Clinical and laboratory variables at day 1 and day 7 for the 20 patients.
| Clinical variable | D1 | D7 |
|---|---|---|
| Heart Rate (bpm) | 103.5 ± 20.3 | 85.4 ± 10.3 |
| MAP (mmHg) | 75.7 ± 14.3 | 87.3 ± 15.8 |
| CVP (mmHg) | 11.7 ± 5.1 | 7.9 ± 3.7 |
| Presence of ventilatory support (#pts) | 20 | 13 |
| PEEP (cmH2O) | 8.8 ± 2.6 | 6.6 ± 4.6 |
| FiO2 (%) | 57.8 ± 15.2 | 44 ± 16.1 |
| ScvO2 (%) | 76.3 ± 9.3 | 76 ± 6.8 |
| PvCO2 (mmHg) | 47.3 ± 5.9 | 48.9 ± 6.2 |
| PaCO2 (mmHg) | 43.4 ± 6.7 | 43.3 ± 6.1 |
| Serum lactate (mmol/L) | 4 ± 2.2 | 1.8 ± 1.4 |
| SOFA score | 11.6 ± 2.7 | 6.8 ± 4 |
| Respiratory SOFA score | 2.4 ± 1 | 1.6 ± 0.9 |
| Coagulation SOFA score | 2.4 ± 1.1 | 1.6 ± 1.1 |
| Hepatic SOFA score | 1.3 ± 1.1 | 1.3 ± 1.4 |
| Cardiovascular SOFA score | 3.4 ± 0.9 | 0.6 ± 1.2 |
| Renal SOFA score | 2.1 ± 1.2 | 1.6 ± 1.6 |
| Diuresis (ml/die) | 2006.2 ± 1323.7 | 2944.7 ± 1870.2 |
| Platelet count (×103 cells/mm3) | 63.8 ± 50.8 | 96.9 ± 55.9 |
| Creatinine (mg/dL) | 2.3 ± 1.1 | 1.8 ± 1.5 |
| Biliuribin (mg/dL) | 3 ± 3.5 | 4.6 ± 7.6 |
| Arterial pH | 7.4 ± 0.1 | 7.4 ± 0.1 |
| PaO2 (mmHg) | 115.3 ± 48.3 | 115 ± 44.9 |
| Venous pH | 7.4 ± 0.1 | 7.4 ± 0.1 |
| PvO2 (mmHg) | 45.1 ± 5.9 | 42.9 ± 6.3 |
| Use of renal replacement therapy (#pts) | 3 | 3 |
Data are presented as mean ± SD. No significant differences were found between D1 and D7. MAP, mean arterial pressure; CVP, central venous pressure; PEEP, positive end-expiratory pressure; FiO2, inspired oxygen fraction; ScvO2, central venous O2 saturation; PvCO2, venous partial pressure of CO2; PaCO2, arterial partial pressure of CO2; PaO2, arterial partial pressure of O2; PvO2, central venous partial pressure of O2.